resource-symbol

International Restless Legs Syndrome Study Group Rating Scale (IRLS)

Allen Richard P; Walters Arthur S

Distributed by Mapi Research Trust

Distributed by Mapi Research Trust

default distrib
 

Basic description

A patient-version also exists: IRLS-PV (16 items). This version was adapted from the IRLS to facilitate patient understanding in order to complete the scale without guidance from an investigator.

Authors

Allen Richard P; Walters Arthur S

Copyright
IRLS © IRLS Study Group 2001 – All Rights Reserved
Objective
To measure the severity of Restless Legs Syndrome (RLS)
Therapeutic area
  • Nervous System Diseases
  • Mental Disorders
Therapeutic indication

Restless Legs Syndrome

Type of Clinical Outcome Assessment (COA)
  • PRO PRO
Original language(s)
  • English for the USA
Bibliographic reference(s) of the original questionnaire

Allen RP, Kushida CA, Atkinson MJ; RLS QoL Consortium. Factor analysis of the International Restless Legs Syndrome Study Group's scale for restless legs severity. Sleep Med. 2003 Mar;4(2):133-5

Walters AS, LeBrocq C, Dhar A, Hening W, Rosen R, Allen RP, Trenkwalder C; International Restless Legs Syndrome Study Group. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med. 2003 Mar;4(2):121-32


Contact and conditions of use

Authors

Allen Richard P; Walters Arthur S

Arthur S Walters, Richard P Allen for the International Restless Legs Syndrome Study Group

- Arthur S Walters Publications (PubMed)

- Richard P Allen Publications (PubMed)

Contact information

Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon
France
Telephone: +33 (0)4 72 13 65 75

Conditions of use

Non-Funded Academic Users

Please consult the online distribution tab below for our automated licensing and distribution process.

Other Users

  1. All requests have to be submitted through our online request management (Tutorials are available on our FAQs)
  2. In order to accelerate the process, you may attach the completed User Agreement (link below) to your online request
  3. Send the user agreement signed hard copy by regular mail to Mapi Research Trust, as we need it for our records
  4. Our PROVIDE team will get back to you with the needed information in a timely manner

Access fees

Transfer of rights to use and reproduce the Questionnaire

(Owner’s Royalty Fees)

 

COMMERCIAL USERS in clinical trials

Cost per study

Based on the number of administrations per study:

less than 50 administrations:

3 675 Euros*

From 50 to 199 administrations:

7 350 Euros*

From 200 to 499 administrations:

15 750 Euros*

From 500 to 999 administrations:

21 000 Euros*

FROM 1.000 administrations:

 

26 250 Euros*

COMMERCIAL USERS

IN COMMERCIAL EPIDEMIOLOGIC/ OBSERVATIONAL/ MARKETING STUDIES /  PROJECTS

Cost per study

Based on the number of administrations per study:

COST PER PROJECT INCLUDING 1 000 administrations/ reproductions:

3 675 € Euros*

Between 1001 and 2500 administrations/ reproductions:

3 675 € Euros* + 1.80 Euros* per administration/ reproduction

Between 2501 and 5000 administrations/ reproductions:

3 675 € Euros* + 1.60 Euros* per administration/ reproduction

From 5001 administrations/ reproductions:

3 675 € Euros* + 1.40 Euros* per administration/ reproduction

FUNDED ACADEMIC USERS

COST PER STUDY

n/a

COST PER LANGUAGE

n/a

MRT’s Distribution Costs

COMMERCIAL USERS

COST PER STUDY

1 000 Euros*

COST PER AVAILABLE LANGUAGE

500 Euros*

FUNDED ACADEMIC USERS

COST PER STUDY

300 Euros*

COST PER AVAILABLE LANGUAGE

50 Euros*

NOT FUNDED ACADEMIC USERS

COST PER STUDY

n/a

COST PER AVAILABLE LANGUAGE

n/a

Author Website(s)

Additional information on the IRLS website

Review copy

Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust.

Online distribution

For Non-Funded Academic Studies

The following licensing process is restricted to academic users:

  • Who do not receive specific funding for their study
  • Who intend to use the questionnaire in individual clinical practice or research study

Should you not correspond to this category of users, please send us a request.

Note: This site aims at providing you with the original version and existing translations of the questionnaire. However some modules/versions may not be downloadable in the language you need.

Login

To access this section, please complete a client account.

Languages

Original language(s)

  • English for the USA

Translations

The list of translations may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study. This list is subject to constant changes, therefore please check the status of translations with Mapi Research Trust / the developers / copyright holders / distributors.

IRLS

Afrikaans for South Africa*
Arabic for Saudi Arabia*
Cebuano for the Philippines*
Czech for Czech Republic*
Danish for Denmark*
Dutch for Belgium (Flemish)*
Dutch for the Netherlands*
English for Canada*
English for the Philippines*
English for the UK*
Farsi for Iran*
Finnish for Finland*
French for Belgium*
French for Canada*
French for France*
French for Switzerland*
German for Austria*
German for Germany*
German for Switzerland*
Greek for Greece*
Hungarian for Hungary*
Italian for Italy*
Italian for Switzerland*
Japanese for Japan*
Korean for Korea*
Mandarin for China
Mandarin for Taiwan
Norwegian for Norway*
Polish for Poland*
Portuguese for Portugal*
Russian for Russia*
Serbian for Serbia*
Slovak for Slovakia*
Spanish for Spain*
Spanish for the USA*
Swedish for Sweden*
Tagalog for the Philippines*
Turkish for Turkey*
* Performed by Mapi

Conditions to translate

Academic Translation

Please submit a request to sign a translation agreement and to obtain Linguistic Validation Guidelines. To submit a request, please consult our FAQs.

Commercial Users

Please submit a request to sign a translation agreement. To submit a request, please consult our FAQs.

Last update: February 2017
For additional information, please submit a request. More information on our FAQs.

YOU MIGHT ALSO BE INTERESTED IN:

PROLABELS symbol PROLABELS: 8 indications